Affordable Epilepsy treatment in India will became easy by Sun Pharma’s Brivaracetam. Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries … Read More
ICRA upgrades rating and outlook of Lincoln Pharmaceuticals. The rating agency ICRA Ltd has upgraded ratings and outlook of Lincoln Pharmaceuticals Ltd. ICRA has upgraded rating of company’s long-term bank … Read More
Torrent Pharma announces Q3 FY21 results. India: Indiarevenues at Rs 930 crores grew by 7% As per AIOCD data set, Q3FY21 growth was 8% v/s IPM growth of 6% Growth … Read More
Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302, 912460) today announced its consolidated results for the Second Quarter (Q2) and Half Year (H1) ended September 30, 2020. Consolidated Financial Highlights § Balance … Read More
Torrent Pharma announces Q2 FY21 results EBITDA grows by 12% driven by recovery in India and productivity gains Revenues & profitability: Revenues at Rs. 2,017 crores were up by 1% … Read More
